Prevalence Of Hypertension And Its Associated Risk Factors Among The Employees Of Khyber Medical University, A Cross Sectional Study
DOI:
https://doi.org/10.69591/jcihs.3.2.2Keywords:
Hypertension, Prevalence, Risk Factors, University Employees, PakistanAbstract
Background:
Hypertension is a major modifiable risk factor for cardiovascular disease and a leading cause of morbidity and mortality worldwide. Despite its growing burden in developing countries, data on hypertension prevalence among institutional employees in Pakistan remain limited.
Objective:
To determine the prevalence of hypertension and identify associated risk factors among employees of Khyber Medical University (KMU).
Methods:
A descriptive cross-sectional study was conducted among 165 KMU employees aged 21–60 years. Data were collected using a validated structured questionnaire covering sociodemographic characteristics, lifestyle factors, and medical history. Anthropometric measurements were recorded, and blood pressure was measured using a calibrated mercury sphygmomanometer. Data were analyzed using SPSS version 26, and results were expressed as frequencies and percentages.
Results:
Among the participants, 86.1% were males and 13.9% were females. The majority (55.8%) belonged to the 31–45-year age group. Pre-hypertension was the most common blood pressure category (69.7%), followed by stage 1 hypertension (20.0%) and stage 2 hypertension (4.8%). A family history of hypertension was present in 39.4% of participants. Smoking was reported by 25.5% of employees, while varying levels of physical activity were observed. Most participants reported normal dietary salt intake, and only 8.8% were on antihypertensive medication. Pre-hypertension and hypertension were predominantly observed in the 31–45-year age group.
Conclusion:
A high prevalence of pre-hypertension and hypertension was observed among KMU employees, particularly among middle-aged adults. The findings highlight the need for regular blood pressure screening, lifestyle modification, and workplace-based health promotion programs to reduce the future burden of cardiovascular disease.
References
1: World Health Organization. World Health Report. Mental Health: New Understanding, New Hope. Geneva: WHO, 2001.
2: Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens 2004; 18(8): 545-51.
3: Rampal L, Rampal S, Azhar MZ, Rahman AR. Prevalence, awareness, treatment and control of hypertension in Malaysia: A national study of 16,440 subjects. Public Health 2008; 122: 11–18.
4: Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002 ; 14(360) :1903-13.
5: Ezzati M, Lopez AD, Rodgers A, Vander HS, Murray CJ, and the Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347–60.
6: World Health Organization. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.
7: Whitworth JA. World Health Organization/International Society of Hypertension statement on management of hypertension. WHO, ISH Writing Group. J Hypertens 2003; 21: 1983–92.
8: Ministry of Health. Third National Health and Morbidity Survey 2006. NHMS III Report 2008.
9: Gazianoa TA, Bitton A, Anand S, Weinstein MC, & for the International Society of Hypertension. The global cost of nonoptimal blood pressure 2009; 27(7): 1472–1477.
10: Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation 2005; 112: 3562–8
11: Sharma S, Kortas C. Hypertension. Emedicine. Available on URhttp://emedicine.m edscape.com/article/241381-overview (accessed 18 January 2010)
12: Hypertension. Wikipedia, the free encyclopedia. Available on URLhttp://en.wikipedia.or g/wiki/Hypertension#cite_note-pmid7707630-121 (accessed 18
13: January (2010)
14: Blood pressure. Wikipedia, the free encyclopedia. Available onURLhttp://en.wikipedia.or g/wiki/Blood_pressure (accessed 18 January 2010)
15: Department of Health and Human Services (US). The Seventh Report of the Join National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. NIH Publication No. 04-5230 August 2004 available on URLhttp://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf (accessed 15 January20.
16: Health and Vital Statistics: I. General Health Statistics. Taipei, Re- public of China: Department of Health, Executive Yuan; 1996:88.
17: Reynolds E, Baron RB. Hypertension in women and the elderly. Post- grad Med . 1996;100:58–69.
18: Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med. 1993;153:154–183.
19: Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH. Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet . 1995;345:825–829.
20: Vokonas PS, Kannel WB, Cupples LA. Epidemiology and risk of hy- pertension in the elderly: the Framingham study. J Hypertens. 1988; 6(suppl 1):S3–S9.
21: Pathy SJ.Hypertension and associated disease in elderly patients. J.Hypertens. 1988;6(suppl 1):S37–S40.
22: Fletcher A, Bulpitt C. Epidemiology of hypertension in the elderly. J Hypertens. 1994;12(suppl 6):S3–S5.
23: Whelton PK. Epidemiology of hypertension. Lancet. 1994;34:101–106.
24: Potter JF. Hypertension and the elderly. Brit Med Bull. 1994;50:408–419
25: M, HoranM, Labarthe D. Prevalence of Hypertension in the US Adult Population. Hypertension 1995; 25:305-13. Lewington S, Clarke R, Qizilbash N et al. Age-specific rel-
26: evance of usual blood pressure to vascular mortality: A meta- analysis of individual data for one million adults in 61 prospec- tive studies. Lancet 2002; 360:1903-13. Vasan RS, Beiser A, Seshadri S. Residual lifetime risk for de-
27: veloping hypertension in middle-aged women and men. The Framingham Heart Study. JAMA 2002; 287:1003-10.
28: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure table NIH Publication No. 04-5230; 2004: 12.
29: Lawes CM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371(9623):1513–8.
30: Tabriz JS, Sadeghi-Bazargani H, Farahbakhsh M, Nikniaz L, Nikniaz Z. prevalence and associated factors of prehypertension and hypertension in Iranian population: The lifestyle promotion project (LPP). PLoS one.2016;
31: Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the united state: National Health and Nutrition Examination Survey, 2011-2012. NCHS Data Brief[internet]. 2013;1-8. Avaliable from: http://www.ncbi.nlm.gov/pubmed/24171916.
32: Yu QIN, Liu B, Na R, Zhong- A. ORAL SESSION 16 PREVALENCE AND RISK FACTORS OF HYPERTENSION AMONG RESIDENTS IN COUNTRY OF DALIAN ZHUANGHE POPULATION IN.
2016;2016.
33: Siddiqui H, Anjum Q, Omair A, Usman J, Rizvi R, Ashfaq T. Original Article Risk factors assessment for hypertension in a squatter settlement of Karachi.2005;55(9):390-2.
34: Repport RS. Silent killer. N J Med.1999;96:41-3.
Published
Issue
Section
License
Copyright (c) 2026 Tayyaba Taj, Haleem Ali , Wajeha Taj
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under a CC-BY 4.0 License.
